Edap TMS SA ADR EDAP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $7.28
- Day Range
- $7.03–7.36
- 52-Week Range
- $3.60–12.23
- Bid/Ask
- $6.80 / $7.35
- Market Cap
- $269.37 Mil
- Volume/Avg
- 31,597 / 39,877
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.12
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 307
- Website
- https://www.edap-tms.com
Valuation
|
Metric
|
EDAP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.29 |
Price/Sales | 4.12 |
Price/Cash Flow | — |
Price/Earnings
EDAP
Financial Strength
|
Metric
|
EDAP
|
|---|---|
Quick Ratio | 2.27 |
Current Ratio | 2.84 |
Interest Coverage | −93.16 |
Quick Ratio
EDAP
Profitability
|
Metric
|
EDAP
|
|---|---|
Return on Assets (Normalized) | −16.63% |
Return on Equity (Normalized) | −25.14% |
Return on Invested Capital (Normalized) | −23.86% |
Return on Assets
EDAP
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MCK
| McKesson Corp | Gkljchvx | Xwvbcdc | $71.0 Bil | |
COR
| Cencora Inc | Cwpkqcckq | Bvwpyhl | $48.0 Bil | |
CAH
| Cardinal Health Inc | Xchsmqqm | Tbczmf | $25.1 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Dhr | $8.6 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Mmss | $8.6 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Jjdsx | $8.2 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Sfqfv | $8.2 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Fvykw | $7.6 Bil | |
MEPDF
| Medipal Holdings Corp | — | Pywj | $3.3 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Xqxv | $3.3 Bil |